🏛️ Verified NIH Record • Updated 2026-08-14

A Study to Evaluate V181 Dengue Vaccine in Healthy Participants 2 to 17 Years of Age (V181-005/MOBILIZE-1) (NCT07013487)

🟢 Recruiting Phase3 💊 Investigational Drug / Biologic Sponsor: Merck Sharp & Dohme LLC

🩺 Plain-English Summary (8th-Grade Level)

The purpose of this study is to demonstrate that V181 is safe and well tolerated, elicits an immune response, and reduces the frequency of virologically confirmed dengue (VCD) of any severity, due to any of the 4 dengue serotypes, regardless of dengue serostatus at baseline in children 2 to 17 years of age.

Who can join: Review the eligibility criteria below.

Location: Jatinegara Primary Health Center ( Site 0102) — East Jakarta, Jakarta Special Capital Region

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (36 Sites)

  • Jatinegara Primary Health Center ( Site 0102) — East Jakarta, Jakarta Special Capital Region
  • Cipayung Primary Health Center ( Site 0105) — East Jakarta, Jakarta Special Capital Region
  • Dr Cipto Mangunkusumo Hospital-Pediatrics ( Site 0101) — Jakarta, Jakarta Special Capital Region
  • Kelapa Gading Primary Health Center ( Site 0104) — North Jakarta, Jakarta Special Capital Region
  • Pasar Minggu Primary Health Center ( Site 0103) — South Jakarta, Jakarta Special Capital Region
  • University Malaya Medical Centre-Department of Paediatrics ( Site 0025) — Lembah Pantai, Kuala Lumpur
  • Hospital Sibu ( Site 0021) — Sibu, Sarawak
  • Hospital Ampang ( Site 0028) — Ampang, Selangor
  • Hospital Al-Sultan Abdullah - Universiti Teknologi MARA ( Site 0029) — Bandar Puncak Alam, Selangor
  • Sunway Medical Centre ( Site 0027) — Petaling Jaya, Selangor
  • Hospital Tunku Azizah-Paediatric ( Site 0022) — Kuala Lumpur,
  • Health Index Multispecialty And Lying-In Clinic ( Site 0042) — Bacoor, Cavite
  • Chong Hua Hospital ( Site 0051) — Cebu City, Cebu
  • Norzel Medical and Diagnostic Clinic Foundation Corp ( Site 0044) — Cebu City, Central Visayas (Region VII)
  • West Visayas State University Medical Center ( Site 0045) — Iloilo City, Iloilo
  • Philippine General Hospital ( Site 0041) — Manila, National Capital Region
  • University of the Philippines Manila ( Site 0047) — Metro Manila, National Capital Region
  • Clinical Research Investigator Group ( Site 0110) — Bayamón,
  • San Juan Bautista School of Medicine - Clinical Research Unit ( Site 0114) — Caguas,
  • Ponce Medical School Foundation Inc./CAIMED Center ( Site 0112) — Ponce,
  • Wellness clinical Research Vega Baja ( Site 0116) — Vega Baja,
  • National University Hospital-Paediatrics ( Site 0001) — Singapore, Central Singapore
  • KK Women's and Children's Hospital ( Site 0002) — Singapore, Central Singapore
  • Tan Tock Seng Hospital ( Site 0003) — Singapore, Central Singapore
  • Chulalongkorn University-Pediatrics ( Site 0063) — Bangkok, Bangkok

💰 Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
🏛️ View Official NIH Record ↗